Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lady-Comp fertility monitor can help prevent the risk of breast cancer
  • USA - English


News provided by

Lady-Comp UK

Oct 23, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Natural family planning is the best option for every woman's health
Natural family planning is the best option for every woman's health

London, UK (PRWEB UK) 23 October 2013 -- Birth control pills as Group 1 carcinogen

The World Health Organization officially labels combined oral contraceptives as a Group 1 Carcinogen, on the same list as other more publicised causes of cancer such as asbestos, tobacco, and tanning booths. Yet, the medical community continues to prescribe the birth control pill for everything from acne to mood swings, with the thought that the benefits outweigh the risks.

According to the World Health Organization, years of scientific research data has shown the following:

Users of combined oral contraceptives have a higher rate of breast cancer prior to age 35 as well as prior to age 45.

Post this
  • The incidents of breast cancer increase proportionately with the length of use of combined oral contraceptives prior to the birth of the first child
  • Users of combined oral contraceptives have a higher rate of breast cancer prior to age 35 as well as prior to age 45
  • Women who have used combined oral contraceptives within the previous 5 to 10 years have a higher risk of breast cancer

Risk of breast cancer quadrupled before age of 18

Further supporting the World Health Organization’s classification, a 2006 study by the Mayo Clinic revealed that breast cancer risk increases 50% for women taking oral contraceptives four or more years before a full-term pregnancy. Additionally, a 2009 study by the Fred Hutchinson Cancer Research Center found women starting the pill before age 18 nearly quadruple their risk of breast cancer.

Likelihood of breast cell mutations

Why is this the case? As it turns out, the combination of estrogen and progesterone in the birth control pill functions as a genotoxin in the body. It encourages the multiplication of breast tissue, and can actually irreparably damage the DNA contained within that tissue. An increased number of cells in the breasts lead to a greater likelihood of mutations in cell division, which can ultimately result in cancer. Even more frightening, estrogen will cause any cells in the breast tissue that are already cancerous to develop and multiply more rapidly.

The right to be informed: anti-implantation mechanism of the pills and coils

Additionally many doctors are concerned about the fact that women often are not informed that the birth control pill can also cause an chemical abortion as well as prevent pregnancy. One medical journal declared, “If any mechanism of any OC [Oral Contraceptive] violates the morals of any particular woman, the failure of the physician or care provider to disclose this information would effectively eliminate the likelihood that the woman’s consent was truly informed and would seriously jeopardise her autonomy.

Hormonal pills and some other “birth control’ methods like intrauterine device (coils) very often act in anti-implantation way – while using them, a woman can still have “breakthrough ovulation”, which occurs in millions of women each year. A woman can still conceive a baby (embryo), who because of synthetic hormones cannot attach to the uterine lining and dies!

The pill’s third mechanism is to change the lining of the endometrium (the lining of the womb), which creates a hostile environment for a newly created human life. The tiny baby cannot implant and is spontaneously aborted by the body - more about the full list of side effects related with taking of hormonal pills or using IUD (coil) and why they also act in anti-implantation way, can be read here: The truth about birth control pills and coils - side effects list

Natural Family Planning - healthy and reliable alternative

For all women who are looking for a natural and healthy way of birth control method without the need for any contraceptives, Lady-Comp is a perfect choice. Lady-Comp® is an intelligent fertility monitor, a next-generation computer that learns, analyses and indicates ovulation, fertile and non-fertile days with 99.3% premium accuracy, which is free of invasive hormones and side effects. More about Lady-Comp can be read here: https://www.lady-comp.co.uk/en/birth-control/lady-comp-pearly/.

About Lady-Comp UK:

Lady-Comp UK is the only authorised distributor of Lady-Comp® for the UK and Ireland – the most effective fertility & natural birth control & family planning computer available on the market. Lady-Comp is manufactured by Valley Electronics headquartered in Germany – the purpose of the company was the worldwide sale of Lady-Comp, the first natural birth control & family planning monitor in the world with the highest effectiveness, without the need for any contraceptives and with no side effects.

Today Lady-Comp is ISO certified and is approved as natural contraception / family planning device in Europe and ovulation predictor in the US, enjoying tremendous confidence among women as Europe's most trusted and recommended natural family planning monitor.

Lady-Comp UK official website: http://www.lady-comp.co.uk

Luke Manczak, Lady-Comp UK, http://www.lady-comp.co.uk, +353 871357699, [email protected]

Modal title

Lady Comp - natural contraception for every healthy conscious woman
Lady Comp - natural contraception for every healthy conscious woman
Lady Comp - natural contraception for every healthy conscious woman

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.